Mangoceuticals, Inc. Common Stock
MGRXMangoceuticals, Inc. (MGRX) is a biopharmaceutical company focused on the development and commercialization of innovative nutraceutical and pharmaceutical products. The company leverages its expertise in formulation science to create health and wellness products that address various medical and nutritional needs. Mangoceuticals aims to integrate natural ingredients with advanced biomedical research to bring effective solutions to consumers.
Company News
Mangoceuticals launches weight-management programs MangoRx Direct and PeachesRx Direct, enabling patients to access FDA-approved GLP-1 medications like Zepbound and Wegovy through telehealth consultations at $99 per month.
Mangoceuticals, a health and wellness company, has acquired the intellectual property and assets of Smokeless Technology Corp., a Canadian-based pouch innovation company. This acquisition will allow Mangoceuticals to expand into the growing oral pouch delivery market. The company has also appointed Tim Corkum, a former executive at Philip Morris,...
Mangoceuticals, a health and wellness company, has appointed Dr. Douglas Christianson as the new Director of Medical Research and Product Innovation. Dr. Christianson will lead the company's product development efforts, particularly in areas like erectile dysfunction, hair growth, weight loss, and hormone replacement therapies.
Dallas, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth, weight loss and hormone replacement therapies, is pleased to a...
Dallas, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth, weight loss and hormone replacement therapies, is pleased to a...
